Six people told AP that FDA scientists opposed the draft policy. Comments are open for two weeks, and former FDA official Peter Lurie calls it a pre-election nod to MAHA.
Recap by typeshit. Full story at CNN.
Lincoln Journal Star reports FDA advisors are weighing whether seven unapproved peptides can be used in some compounded prescriptions.
The segment covers a federal draft policy that could open access to some injectable peptides, alongside proposed changes to infant formula nutrients.
The longevity researcher argues the FDA system has grown too slow and costly, saying it favors big drugmakers. He offers this as the reason reform efforts emerged.
TikTok's health content rules bar weight-management claims and GLP-1 promos, with removals or account penalties for creators who break them.
A Cary-based company pulled its GLP-1 injections following attention from the FDA. The Business Journals has the details on the recall.
Novo says the Denver data, Nov. 5 to 9, include a real-world comparison of Wegovy 2.4 mg and resmetirom in MASH patients, picked as a Poster of Distinction.
Loading…